A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age
Condition:   Measles; Mumps; Rubella; Chickenpox Interventions:   Biological: Investigational MMRV(H)NS vaccine;   Biological: Investigational MM(H)RVNS vaccine;   Biological: Investigational M(L)M(L)R(L)V(L)NS vaccine;   Biological: Marketed MMRV_Lot 1 and Lot 2 vaccine Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials

Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience
Condition:   Measles Intervention:   Sponsor:   Marmara University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2022 Category: Research Source Type: clinical trials